Bio-Layer CEO steps down

By Ruth Beran
Friday, 17 February, 2006

Jason Armstrong has stepped down as CEO of Bio-Layer.

Founded in 2000 as Polymerat, Bio-Layer listed on the ASX in November last year through SSH Medical to form a parent company, BioLayer Corp (ASX:BLS), and an unlisted operating subsidiary, Bio-Layer.

"It was just the right time for me to go off and start doing some other things given my involvement in the company now for two or three years," said Armstrong, whose last day in the office was on Wednesday.

Since listing, BioLayer Corporation has not had a CEO or managing director, but Armstrong said the company already had some candidates lined up for the new position. The new CEO will head both the listed company BioLayer Corporation and the subsidiary Bio-Layer.

Armstrong will remain on the board of the listed company BioLayer Corporation.

Until the new CEO is appointed, BioLayer Corporation director Carrie Hillyard will provide some day-to-day management of the science-based staff at the company's Eight Mile Plains facility.

Asked what he would do next, Armstrong said: "I do have some interim contracts with US companies, but I will stay in Australia while I do them and they're only short term. What I do after that I haven't decided."

Related News

Noxopharm says paper reveals science behind its immune system platform

Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...

Neurosensing/neurostimulation implants session to be held on Monday

On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd